HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 198 filers reported holding HERON THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 2.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $202,693 | -32.5% | 134,234 | +11.7% | 0.00% | – |
| Q4 2022 | $300,508 | -48.5% | 120,203 | -13.0% | 0.00% | -100.0% |
| Q3 2022 | $583,000 | +77.7% | 138,217 | +17.2% | 0.00% | – |
| Q2 2022 | $328,000 | -57.7% | 117,886 | -13.2% | 0.00% | -100.0% |
| Q1 2022 | $776,000 | -40.7% | 135,833 | -5.2% | 0.00% | 0.0% |
| Q4 2021 | $1,308,000 | +12.9% | 143,262 | +32.1% | 0.00% | 0.0% |
| Q3 2021 | $1,159,000 | -9.5% | 108,416 | +31.3% | 0.00% | 0.0% |
| Q2 2021 | $1,281,000 | +21.2% | 82,587 | +26.5% | 0.00% | 0.0% |
| Q1 2021 | $1,057,000 | -65.4% | 65,271 | -54.8% | 0.00% | 0.0% |
| Q4 2020 | $3,057,000 | +28.5% | 144,369 | -10.1% | 0.00% | 0.0% |
| Q3 2020 | $2,379,000 | +1.8% | 160,563 | +1.0% | 0.00% | -50.0% |
| Q2 2020 | $2,338,000 | +68.1% | 158,935 | +34.1% | 0.00% | +100.0% |
| Q1 2020 | $1,391,000 | -68.1% | 118,495 | -36.2% | 0.00% | -66.7% |
| Q4 2019 | $4,364,000 | +222.8% | 185,676 | +154.2% | 0.00% | +200.0% |
| Q3 2019 | $1,352,000 | +52.8% | 73,042 | +53.4% | 0.00% | 0.0% |
| Q2 2019 | $885,000 | -34.4% | 47,609 | -13.8% | 0.00% | 0.0% |
| Q1 2019 | $1,350,000 | -44.4% | 55,235 | -41.1% | 0.00% | -66.7% |
| Q4 2018 | $2,430,000 | +35.0% | 93,705 | +64.7% | 0.00% | +50.0% |
| Q3 2018 | $1,800,000 | -16.9% | 56,903 | +2.0% | 0.00% | 0.0% |
| Q2 2018 | $2,166,000 | +27.4% | 55,782 | -9.4% | 0.00% | 0.0% |
| Q1 2018 | $1,700,000 | +93.0% | 61,593 | +26.4% | 0.00% | +100.0% |
| Q4 2017 | $881,000 | -11.2% | 48,724 | -20.7% | 0.00% | 0.0% |
| Q3 2017 | $992,000 | -28.2% | 61,423 | -38.4% | 0.00% | 0.0% |
| Q2 2017 | $1,382,000 | -36.0% | 99,744 | -30.8% | 0.00% | -50.0% |
| Q1 2017 | $2,161,000 | +392.3% | 144,061 | +329.8% | 0.00% | – |
| Q4 2016 | $439,000 | -45.8% | 33,522 | -28.7% | 0.00% | -100.0% |
| Q3 2016 | $810,000 | -20.0% | 47,040 | -16.0% | 0.00% | 0.0% |
| Q2 2016 | $1,012,000 | -3.2% | 56,002 | +1.8% | 0.00% | 0.0% |
| Q1 2016 | $1,045,000 | +51.2% | 55,020 | +112.7% | 0.00% | 0.0% |
| Q4 2015 | $691,000 | +161.7% | 25,869 | +138.8% | 0.00% | – |
| Q3 2015 | $264,000 | -67.6% | 10,834 | -58.6% | 0.00% | -100.0% |
| Q2 2015 | $815,000 | +252.8% | 26,185 | +57.7% | 0.00% | – |
| Q1 2014 | $231,000 | – | 16,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 21,288 | $250,000 | 19.87% |
| TANG CAPITAL MANAGEMENT LLC | 2,896,904 | $34,010,000 | 4.78% |
| PFM Health Sciences, LP | 2,481,917 | $29,138,000 | 2.39% |
| Iron Triangle Partners LP | 500,000 | $5,870,000 | 2.27% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 777,599 | $9,129,000 | 1.72% |
| Pekin Hardy Strauss, Inc. | 588,732 | $6,912,000 | 1.55% |
| First Light Asset Management, LLC | 691,400 | $8,117,000 | 1.39% |
| Congress Park Capital LLC | 111,045 | $1,304,000 | 1.18% |
| Mesirow Financial Investment Management, Inc. | 15,135 | $178,000 | 1.12% |
| Elk Creek Partners, LLC | 509,174 | $5,978,000 | 1.03% |